| Title |
Credit (Amnt/Type) |
Est.Time |
Expires |
Advances in the Treatment of Bladder Cancer:
Treatment of High-Risk Non–Muscle-Invasive TCC—An Ongoing Debate
|
0.75 / AMA PRA Category 1 Credit(s)™
|
45 Minutes |
March 31, 2009 |
CME from The Journal of the American Academy of Physician Assistants
(November 2008)
|
1.00 / AAPA Category I CME Credit
|
1 Hour |
November 30, 2009 |
Current Issues in the Management of Bladder Cancer:
Impact of the Updated AUA Guidelines on Therapeutic Decision Making
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
August 31, 2009 |
Current Issues in the Management of Bladder Cancer:
Practical Strategies for Improving Outcomes in Patients With Non–Muscle-Invasive Bladder Cancer
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
November 30, 2009 |
Developmental Therapeutics in Advanced Breast Cancer:
Novel Mechanisms and Future Directions
|
1.75 / AMA PRA Category 1 Credit(s)™
|
1 Hour and 45 Minutes |
October 31, 2009 |
Emerging Targeted Therapies for Hematologic Malignancies:
Leaving a Genetic and Epigenetic Imprint for Better Outcomes
|
1.50 / AMA PRA Category 1 Credit(s)™
|
90 Minutes |
November 30, 2010 |
|
Preoperative Therapy for Patients with Resectable Adenocarcinoma of the Pancreatic Head
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
January 15, 2010 |
|
Recent Advances In The Management Of Cutaneous T-Cell Lymphoma
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
October 15, 2009 |
|
Recent Advances in The Treatment Of Hematologic Malignancies
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
January 15, 2010 |
Recent Advances in the Treatment of Hematologic Malignancies:
Highlights from the 50th Annual Meeting of ASH
|
1.00 / AMA PRA Category 1 Credit(s)™
|
1 Hour |
April 30, 2010 |